Alterations in myosin force transmission due to the removal of the light chain binding domain are sufficient to trigger the development of hypertrophic cardiomyopathy in a mouse model.
No takes yet. Share an insight, caveat, or question.
Mutant myosin suffices to induce HCM features in mice; leaves open human translation and therapeutic targeting.
Welikson et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: